A comparative evaluation of the treatment of Schitosoma mansoni with niridazole and potassium antimony tartrate.
D000328:Adult; D000871:Anthelmintics / Q000627:therapeutic use*; D000965:Antimony / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004639:Emetics / Q000627:therapeutic use; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009560:Niridazole / Q000009:adverse effects / Q000627:therapeutic use; D010270:Parasite Egg Count; D012550:Schistosoma mansoni; D012552:Schistosomiasis / Q000188:drug therapy*; D013644:Tartrates / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*
D000871:Anthelmintics; D004639:Emetics; D007093:Imidazoles; D013644:Tartrates; D013844:Thiazoles; D000965:Antimony; D009560:Niridazole